With new news this morning that Pfizer will be splitting into three separate businesses I am intrigued because spinoffs have shown they are seriously profitable.
Pfizer itself has great fundamentals. Higher ROE, lower Debt, and large margins. The spinoffs could be equally as strong and may be undervalued just due to the nature of being a spin off. I am keeping my eyes open. How about you?
Submitted July 11, 2018 at 08:30AM by sisumoney https://ift.tt/2JcCDOt
No comments:
Post a Comment